Literature DB >> 8694751

Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response.

A Clerk1, J Gillespie-Brown, S J Fuller, P H Sugden.   

Abstract

In ventricular myocytes cultured from neonatal rat hearts, bradykinin (BK), kallidin or BK(1-8) [(Des-Arg9)BK] stimulated PtdinsP2 hydrolysis by 3-4-fold. EC50 values were 6 nM (BK), 2 nM (kallidin), and 14 microM [BK(1-8)]. BK or kallidin stimulated the rapid (less than 30 s) translocation of more than 80% of the novel protein kinase C (PKC) isoforms nPKC-delta and nPKC-epsilon from the soluble to the particulate fraction. EC50 values for nPKC-delta translocation by BK or kallidin were 10 and 2 nM respectively. EC50 values for nPKC-epsilon translocation by BK or kallidin were 2 and 0.6 nM respectively. EC50 values for the translocation of nPKC-delta and nPKC-epsilon by BK(1-8) were more than 5 microM. The classical PKC, cPKC-alpha, and the atypical PKC, nPKC-zeta, did not translocate. BK caused activation and phosphorylation of p42-mitogen-activated protein kinase (MAPK) (maximal at 3-5 min, 30-35% of p42-MAPK phosphorylated). p44-MAPK was similarly activated. EC50 values for p42/p44-MAPK activation by BK were less than 1 nM whereas values for BK(1-8) were more than 10 microM. The order of potency [BK approximately equal to kallidin >> BK (1-8)] for the stimulation of PtdInsP2 hydrolysis, nPKC-delta and nPKC-epsilon translocation, and p42/p44-MAPK activities suggests involvement of the B2 BK receptor subtype. In addition, stimulation of all three processes by BK was inhibited by the B2BK receptor-selective antagonist HOE140 but not by the B1-selective antagonist Leu8BK(1-8). Exposure of cells to phorbol 12-myristate 13-acetate for 24 h inhibited subsequent activation of p42/p44-MAPK by BK suggesting participation of nPKC (and possibly cPKC) isoforms in the activation process. Thus, like hypertrophic agents such as endothelin-1 (ET-1) and phenylephrine (PE), BK activates PtdInsP2 hydrolysis, translocates nPKC-delta, and nPKC-epsilon, and activates p42/p44-MAPK. However, in comparison with ET-1 and PE, BK was only weakly hypertrophic as assessed by cell morphology and patterns of gene expression. This difference could not be attributed to dissimilarities between the duration of activation of p42/p44-MAPK by BK or ET-1. Thus activation of these signalling pathways alone may be insufficient to induce a powerful hypertrophic response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694751      PMCID: PMC1217450          DOI: 10.1042/bj3170109

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  71 in total

Review 1.  Protein kinase C and lipid signaling for sustained cellular responses.

Authors:  Y Nishizuka
Journal:  FASEB J       Date:  1995-04       Impact factor: 5.191

2.  Evidence that ceramide selectively inhibits protein kinase C-alpha translocation and modulates bradykinin activation of phospholipase D.

Authors:  M J Jones; A W Murray
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

3.  Role of bradykinin in protection of ischemic preconditioning in rabbit hearts.

Authors:  M Goto; Y Liu; X M Yang; J L Ardell; M V Cohen; J M Downey
Journal:  Circ Res       Date:  1995-09       Impact factor: 17.367

Review 4.  Kinins and endothelial control of vascular smooth muscle.

Authors:  J V Mombouli; P M Vanhoutte
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

5.  Protective role of bradykinin in cardiac anaphylaxis. Coronary-vasodilating and antiarrhythmic activities mediated by autocrine/paracrine mechanisms.

Authors:  L E Rubin; R Levi
Journal:  Circ Res       Date:  1995-03       Impact factor: 17.367

6.  Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes.

Authors:  R D Minshall; F Nakamura; R P Becker; S F Rabito
Journal:  Circ Res       Date:  1995-05       Impact factor: 17.367

Review 7.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  Evidence that the bradykinin-induced activation of phospholipase D and of the mitogen-activated protein kinase cascade involve different protein kinase C isoforms.

Authors:  K J Clark; A W Murray
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

9.  Ischemic preconditioning protects against infarction in rat heart.

Authors:  Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1992-10

Review 10.  Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

Authors:  W Linz; G Wiemer; P Gohlke; T Unger; B A Schölkens
Journal:  Pharmacol Rev       Date:  1995-03       Impact factor: 25.468

View more
  18 in total

1.  In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.

Authors:  S Drube; C Liebmann
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes.

Authors:  S J Fuller; E L Davies; J Gillespie-Brown; H Sun; N K Tonks
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

3.  Novel bradykinin signalling events in PC-12 cells: stimulation of the cAMP pathway leads to cAMP-mediated translocation of protein kinase Cepsilon.

Authors:  A Graness; A Adomeit; B Ludwig; W D Müller; R Kaufmann; C Liebmann
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

4.  PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors.

Authors:  Alessandra Matavel; Coeli M B Lopes
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

5.  IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro.

Authors:  Anastasia Stavropoulou; Antonios Halapas; Antigone Sourla; Anastassios Philippou; Efstathia Papageorgiou; Apostolos Papalois; Michael Koutsilieris
Journal:  Mol Med       Date:  2009-03-06       Impact factor: 6.354

6.  Docosahexaenoic acid inhibits protein kinase C translocation/activation and cardiac hypertrophy in rat cardiomyocytes.

Authors:  Alicia Castillo; Nargiz Ruzmetov; Kevin A Harvey; William Stillwell; Gary P Zaloga; Rafat A Siddiqui
Journal:  J Mol Genet Med       Date:  2005-07-28

7.  ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes.

Authors:  Andrew K Marshall; Oliver P T Barrett; Timothy E Cullingford; Achchuthan Shanmugasundram; Peter H Sugden; Angela Clerk
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase.

Authors:  Yunbo Ke; Katherine A Sheehan; E Eroume A Egom; Ming Lei; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-12       Impact factor: 4.733

9.  Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes.

Authors:  Anthony J Barron; Stephen G Finn; Stephen J Fuller
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

10.  Stimulation of gene expression in neonatal rat ventricular myocytes by Ras is mediated by Ral guanine nucleotide dissociation stimulator (Ral.GDS) and phosphatidylinositol 3-kinase in addition to Raf.

Authors:  S J Fuller; S G Finn; J Downward; P H Sugden
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.